Article

Why ASCO matters

Author(s):

Debu Tripathy blog image

Debu Tripathy, CURE's editor-in-chief, is in Chicago for the annual meeting of the American Society of Clinical Oncology. He explains why the meeting is so important to clinicians and patients, as well as to the broader oncology community."This is one of the most important hallmark meetings of our profession. It is where the latest updates are presented and also debated," he says. "Ultimately, it's the clinicians and the sometimes the patients who have to decide on what's incorporated into standard care."

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Related Content